Table 1.
Evidence from basic research | ||||||
Cell line/animal | Disease model/treatment | Sample | circRNA | Alteration of expression | Various roles in the pathophysiological mechanism | Reference |
HT22 cells | OGD/R | Cell | mmu-circRNA-015947 | Upregulated | May participate in apoptosis-related, metabolism-related, and immune-related pathways | [62] |
CMVECs | Oxidative stress induced by H2O2 | Cell | circHIPK3 | Upregulated | Overexpression significantly decreased apoptosis and protected CMVECs against H2O2-induced oxidative damages | [78] |
HUVECs | Oxidative stress induced by HG | Cell | circBPTF | Upregulated | Regulate HG-induced HUVEC dysfunction, including apoptosis, inflammation, and oxidative stress | [80] |
SH-SY5Y cells | Oxidative stress induced by H2O2 | Cell | circPRKCI | Downregulated | Alleviate the cytotoxicity induced by H2O2 | [92] |
ARPE-19 cells | Oxidative stress induced by HG | Cell | circRNA_0084043 | Upregulated | May enhance malondialdehyde content and decrease activities of SOD and glutathione peroxidase, resulting in enhancing the oxidative stress in HG-indicated human retinal pigment epithelium ARPE-19 cells | [102] |
Rat Schwann RSC96 cells | Oxidative stress induced by HG | Cell | circACR | Downregulated | Relieve the oxidative stress caused by HG | [95] |
Vascular smooth muscle cells | Hyperglycemia stimulation | Exosomes | circRNA-0077930 | (See the right column) | Its overexpression increases the lactate dehydrogenase activity, reduces the antioxidative stress marker (SOD) activity, and induces senescence | [82] |
H9c2 cells | 100 μM H2O2 treatment | Cell | circNCX1 | Upregulated | Lead to the death of cardiomyocytes in vitro and in vivo, acting as an endogenous miR-133a-3p sponge | [101] |
H9c2 cells | Oxidative stress induced by H2O2 | Cell | circNFIX | Downregulated | Facilitates oxidative stress-induced H9c2 cells apoptosis | [107] |
Mesangial cells | High glucose- (HG-) treated | Cell | circLRP6 | Upregulated | Regulates HG-induced proliferation, oxidative stress, ECM accumulation, and inflammation in mesangial cells via sponging miR-205, upregulating HMGB1, and activating TLR4/NF-κB pathway | [108] |
Rat | ICH | Cortical tissues around the hematoma | rno_circRNA_011054 rno_circRNA_005098 rno_circRNA_012556 |
Upregulated Downregulated |
Promising targets for therapeutic intervention of ICH | [58] |
Chicken | NH3 treatment | Thymuses | circRNA-SMC6 | (See the right column) | Correlated with OXR1, which can protect cells from oxidative damage | [109] |
Mouse | Nrf2 knockout | Substantia nigra | mmu-circRNA-32463 mmu-circRNA-015216 |
Upregulated Downregulated |
A potential regulator of Nrf2-mediated neuroprotection against oxidative stress | [88] |
Mouse | Nrf2 knockout | Corpus striatum | mmu-circRNA-017077 | Downregulated | Participate in Nrf2-mediated Fas-induced apoptosis in a variety of neurological diseases associated with oxidative stress | [88] |
Mouse | tMCAO | Cortical tissue | circ_008018 | Upregulated | Result in brain tissue damage and neurological deficits | [63] |
Mouse | Oxidative stress induced by H2O2 | Cardiac endothelial cells | circHIPK3 | Enriched in exosomes | Promote accelerated cell cycle progression and proliferation | [79] |
Mouse | tMCAO | Cell lysates | circ_008018 circ_015350 circ_016128 circ_011137 circ_001729 circ_006696 |
Upregulated 6 hours reperfusion after transient MCAO Downregulated 6 hours reperfusion after transient MCAO |
Might have functional consequences in controlling the secondary brain damage and neurological dysfunction | [57] |
Mouse | tMCAO | Cell lysates | circDLGAP4 | Downregulated | Decrease neurological deficits and infarct areas and blood-brain barrier (BBB) damage | [60] |
Mouse | Diabetic retinopathy | Cell lysates | circZNF609 | Upregulated | Capillary degeneration and pathological angiogenesis | [73] |
Rat | Coronary atherosclerosis | Coronary artery tissue | circANRIL | In the empty vector and overexpressed cANRIL groups, atherosclerotic plaques and thrombi appeared | Reduced cANRIL expression could prevent coronary AS by reducing vascular EC apoptosis and inflammatory factor expression | [75, 76] |
Mouse | Hypertrophy and heart failure induced by ISO treatment | Cardiomyocytes | mm9_circ_012559, circHRCR | Downregulated | Inhibits cardiac hypertrophy and heart failure by targeting miR-223 and ARC | [99] |
Mouse | MI | Mouse myocardial tissues and mouse blood samples | circCDR1 | Upregulated | May aggravate the oxidative stress in neuronal cells | [94] |
Rat | Renal ischemia-reperfusion | Mouse kidney tissues | circAKT3 | (See the right column) | Involve RI/R injury progression through regulating miR-144-5p/Wnt/β-catenin pathway and oxidative stress | [103] |
Rats | I/R pretreatment with salidroside | Rat heart tissues | circ_0000064 | Upregulated | Have a protective effect on myocardial ischemia-reperfusion injury | [98] |
| ||||||
Evidence from clinical research | ||||||
Disease | Sample | Treatment | circRNA | Alteration of expression | Various roles in the pathophysiological mechanism | Reference |
AIS | Plasma from patients | N/A | circDLGAP4 | Downregulated | Decrease neurological deficits and infarct areas and blood-brain barrier (BBB) damage | [60] |
AIS | Plasma from patients | N/A | circFUNDC1, circPDS5B, circCDC14A | Upregulated | Serve as biomarkers for AIS diagnosis and prediction of stroke outcomes | [61] |
Acute carotid-related cerebrovascular ischemia | Plasma from patients | N/A | The ratio of circRNA-284/miR-221 | Increased | Detect plaque rupture and stroke, as biomarkers in cardiovascular disease | [64] |
Parkinson's disease | Postmortem brain tissues from patients | N/A | circSLC8A1 | Upregulated | In oxidative stress, oxidation itself may increase the circulation of circSLC8A1 in neurons and reduce the expression of SLC8A1 protein | [91] |
Glioma | In glioma tissues from patients and cells (T98G and LN229) | N/A | circSCAF11 | Upregulated | Its knockdown repressed cell proliferation and invasion | [104] |
Intestinal infarction | In the intestinal mucosal tissues of mice and patients undergoing surgery for acute mesenteric arterial embolism, strangulated intestinal obstruction, or incarcerated hernia | I/R | circPRKCB | Upregulated | circPRKCB silencing or miR-339-5p overexpression significantly downregulated p66Shc expression and attenuated oxidative stress levels and I/R injury | [105] |
Atherosclerotic plaques | SMCs and CD68-positive macrophages from patients | N/A | circANRIL | Upregulated | May alter RNA function and confer atheroprotection | [9] |
ARC | Lens epithelial cells from patients | N/A | circHIPK3 | Downregulated | Under oxidative stress, circHIPK3 silencing increased the number of cell death and inhibited cell proliferation | [77] |
Human dental pulp stromal cells (a mesenchymal stromal cell source for regenerative therapy) | Human dental pulp stromal cells | Oxidative stress induced by H2O2 | hsa_circ_0000257 | Upregulated | The hsa_circ_0000257/hsa-miR-9-5p/SIRT1/p53 regulatory axis is likely a novel molecular pathway regulating oxidative stress in hDPSCs | [110] |
Abbreviations: AIS: acute ischemic stroke; ARC: age-related cataract; CMVECs: cardiac microvascular endothelial cells; H2O2: hydrogen peroxide; HUVECs: human umbilical vein endothelial cells; ICH: intracerebral hemorrhage; I/R: ischemia-reperfusion; MI: myocardial infarction; Nrf2: nuclear factor erythroid 2-related factor 2; NH3: ammonia; HG: high glucose; OGD/R: oxygen-glucose deprivation/reoxygenation; SMCs: smooth muscle cells; SOD: superoxide dismutase; tMCAO: transient middle cerebral artery occlusion.